SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Journal article
Barnes E. et al, (2023), Nature medicine, 29, 1760 - 1774
Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
Journal article
Brewitz L. et al, (2023), Journal of Medicinal Chemistry, 66, 2663 - 2680
Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery
Preprint
Ali M. et al, (2023)
A prototype lateral flow assay for detection of orthopoxviruses.
Journal article
Ulaeto DO. et al, (2022), The Lancet. Infectious diseases, 22, 1279 - 1280
Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.
Journal article
Harvala H. et al, (2022), Transfusion, 62, 1347 - 1354
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.
Journal article
Guimond SE. et al, (2022), ACS central science, 8, 527 - 545
TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease
Journal article
Jones EL. et al, (2021), Frontiers in Immunology, 12
Modulation of early host innate immune response by a Fowlpox virus (FWPV) lateral body protein
Preprint
Giotis E. et al, (2020)